Guide
Epilepsy surgery and devices
An overview of surgery and implanted devices for selected people whose seizures continue despite medicine. It explains who may be evaluated and how the treatments differ in what they aim to do.
General information, not medical advice. In an emergency call 911. Full disclaimer
These treatments are for selected people with drug-resistant epilepsy. That means two well-chosen medicines, taken the right way, have not stopped the seizures. [1] Experts advise a referral to a specialized epilepsy center as soon as this is clear. A referral is not a promise of surgery. Most people who are referred do not have surgery. They still gain from the expert care. [2]
The first step is an epilepsy surgery evaluation. It looks for where seizures start. It also checks which treatments may be safe for you. [3]
If you see someone having a seizure, follow the CDC's seizure first aid steps. Call 911 if a seizure lasts longer than 5 minutes, if the person does not wake up, or if they are hurt. [4]
Main treatments
- Responsive neurostimulation (RNS). A small device in the skull watches brain activity. It sends brief pulses when it senses a seizure pattern. The goal is fewer seizures. [5]
- Deep brain stimulation (DBS) for epilepsy. Wires deep in the brain, on both sides, send pulses. The goal is fewer seizures. [6]
- Anterior temporal lobectomy. Surgery removes part of the temporal lobe if seizures start there. [7] In a trial, the goal was freedom from seizures. [8]
- MRI-guided laser ablation (LITT). A laser heats and destroys the small area where seizures start. It is less of an operation than open surgery. [7]
- Stereo-EEG (SEEG). This is a test, not a treatment. Thin wires in the brain for a short time record where seizures start. [3]
Other options: lesionectomy and other focal resections, vagus nerve stimulation, corpus callosotomy, and hemispherotomy. [7]
How the treatments compare
Each row comes from a different study. The people, the outcomes, and the time frames differ. So the rows cannot be compared exactly.
| Treatment | Main goal | Who was studied | Possible harms | Follow-up |
|---|---|---|---|---|
| Temporal lobectomy [8] | Seizure freedom | 80 people with temporal lobe epilepsy in a trial | 4 of 40 people (10 out of 100) had a side effect of surgery | Clinic visits; no device |
| Laser ablation [9] | Seizure freedom | 551 people with temporal lobe epilepsy in 13 studies | 17 out of 100 had a complication | Clinic visits; no device |
| RNS [10] [5] | Fewer seizures | 191 adults in a trial; 256 adults followed up to 9 years | Infection after about 4 out of 100 procedures | Visits to set the device, review of brain data, new battery every few years |
| DBS [11] [12] | Fewer seizures | 110 adults in a trial, followed 5 years | Serious device problems in 34 out of 100 by 5 years; more reports of low mood or memory problems | Visits to set the device |
| Vagus nerve stimulation [13] | Fewer seizures | 439 adults and children in 5 trials | Hoarse voice, cough, shortness of breath | Visits to set the device |
| Corpus callosotomy [14] [15] | Fewer drop seizures | 1,644 people in 49 studies | In children: repeat surgery for 7 out of 100; a disconnection syndrome in 14 out of 100 | Clinic visits; no device |
What the studies found. These are four different outcomes. Keep them apart.
| Treatment | Seizure freedom | Fewer seizures | Fewer drop seizures | Quality of life |
|---|---|---|---|---|
| Temporal lobectomy [8] | At 1 year, 58 out of 100 had no seizures that dim awareness, vs 8 out of 100 on medicine | Fewer seizures that dim awareness | Not reported | Better than with medicine at 1 year |
| Laser ablation [9] | 58 out of 100, pooled across studies | Not reported | Not reported | Not reported |
| RNS [10] [5] | 18 out of 100 had at least 1 seizure-free year during 9 years | Seizures fell by a median of 75% at 9 years | Not reported | Improved and stayed improved |
| DBS [12] | 16 out of 100 had at least 6 seizure-free months during 5 years | Seizures fell by a median of 69% at 5 years | Not reported | Improved at 1 and 5 years |
| Vagus nerve stimulation [13] | Not reported | High settings were about 1.7 times as likely as low settings to cut seizures in half, over 12 to 20 weeks | Not reported | Small benefits; unclear |
| Corpus callosotomy [14] | About 12 out of 100 | Not reported | Drop seizures stopped in about 62 out of 100 | Not reported |
A median is the middle value: half of people did better and half did worse.
About your medicines
RNS and DBS are approved as add-on treatments. They are used along with medicine. [16] [6] Do not stop or change an antiseizure medicine on your own. Any plan to change your medicine should come from your treating team.
Where to learn more
The International League Against Epilepsy keeps a list of expert papers on epilepsy surgery. [17] To find an epilepsy center, see the evaluation guide. It links to a list of centers.
Sources
- Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-1077. Published June 1, 2010. Open source
- Jehi L, Jette N, Kwon CS, et al. Timing of referral to evaluate for epilepsy surgery: expert consensus recommendations from the Surgical Therapies Commission of the International League Against Epilepsy. Epilepsia. 2022;63(10):2491-2506. Published October 1, 2022. Open source
- Lado FA, Ahrens SM, Riker E, et al. Guidelines for specialized epilepsy centers: executive summary of the report of the National Association of Epilepsy Centers guideline panel. Neurology. 2024;102(4):e208087. Published February 1, 2024. Open source
- First Aid for Seizures. Centers for Disease Control and Prevention. Published May 15, 2024. Open source
- Nair DR, Laxer KD, Weber PB, et al. Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. 2020;95(9):e1244-e1256. Published September 1, 2020. Open source
- Premarket Approval Supplement P960009/S219: Medtronic DBS Therapy for Epilepsy. US Food and Drug Administration. Published April 27, 2018. Open source
- Epilepsy and Seizures. National Institute of Neurological Disorders and Stroke. Published March 13, 2026. Open source
- Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311-318. Published August 2, 2001. Open source
- Kerezoudis P, Parisi V, Marsh WR, et al. Surgical outcomes of laser interstitial thermal therapy for temporal lobe epilepsy: systematic review and meta-analysis. World Neurosurg. 2020;143:527-536.e3. Published November 1, 2020. Open source
- Morrell MJ; RNS System in Epilepsy Study Group. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology. 2011;77(13):1295-1304. Published September 1, 2011. Open source
- Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899-908. Published May 1, 2010. Open source
- Salanova V, Witt T, Worth R, et al. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology. 2015;84(10):1017-1025. Published March 1, 2015. Open source
- Panebianco M, Rigby A, Marson AG. Vagus nerve stimulation for focal seizures. Cochrane Database Syst Rev. 2022;7(7):CD002896. Published July 14, 2022. Open source
- Wu X, Ou S, Zhang H, et al. Long-term follow-up seizure outcomes after corpus callosotomy: a systematic review with meta-analysis. Brain Behav. 2023;13(4):e2964. Published April 1, 2023. Open source
- Ye VC, Mansouri A, Warsi NM, Ibrahim GM. Atonic seizures in children: a meta-analysis comparing corpus callosotomy to vagus nerve stimulation. Childs Nerv Syst. 2021;37(1):259-267. Published June 11, 2020. Open source
- Premarket Approval P100026: NeuroPace RNS System. US Food and Drug Administration. Published November 14, 2013. Open source
- Epilepsy Surgery. International League Against Epilepsy. Open source